BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24856851)

  • 1. Molecular pathology of malignant melanoma: changing the clinical practice paradigm toward a personalized approach.
    Bradish JR; Cheng L
    Hum Pathol; 2014 Jul; 45(7):1315-26. PubMed ID: 24856851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferative activity, chromosomal aberrations, and tumor-specific mutations in the differential diagnosis between blue nevi and melanoma.
    Held L; Eigentler TK; Metzler G; Leiter U; Messina JL; Glass LF; Garbe C; Bauer J
    Am J Pathol; 2013 Mar; 182(3):640-5. PubMed ID: 23261261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular testing in malignant melanoma.
    Grossmann AH; Grossmann KF; Wallander ML
    Diagn Cytopathol; 2012 Jun; 40(6):503-10. PubMed ID: 22619125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of malignant melanoma from benign nevus using a novel genomic microarray with low specimen requirements.
    Chandler WM; Rowe LR; Florell SR; Jahromi MS; Schiffman JD; South ST
    Arch Pathol Lab Med; 2012 Aug; 136(8):947-55. PubMed ID: 22849744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetics of melanocytic neoplasia: practical applications for diagnosis.
    Bastian BC
    Pathology; 2004 Oct; 36(5):458-61. PubMed ID: 15370116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of clinical parameters associated with mutational status in metastatic malignant melanoma: a single-centre investigation of 141 patients.
    Schlaak M; Bajah A; Podewski T; Kreuzberg N; von Bartenwerffer W; Wardelmann E; Merkelbach-Bruse S; Büttner R; Mauch C; Kurschat P
    Br J Dermatol; 2013 Apr; 168(4):708-16. PubMed ID: 23528057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cytogenetics of cutaneous melanocytic lesions - diagnostic, prognostic and therapeutic aspects.
    Blokx WA; van Dijk MC; Ruiter DJ
    Histopathology; 2010 Jan; 56(1):121-32. PubMed ID: 20055910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenetics of melanoma: basis for molecular diagnostics and therapy.
    Held L; Eigentler TK; Meier F; Held M; Röcken M; Garbe C; Bauer J
    J Dtsch Dermatol Ges; 2011 Jul; 9(7):510-6. PubMed ID: 21244632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular markers in malignant cutaneous melanoma: gift horse or one-trick pony?
    Martinez SR; Hoon DS
    J Cell Biochem; 2005 Oct; 96(3):473-83. PubMed ID: 16088931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What's new in prognostication of melanoma in the dermatopathology laboratory?
    Bangash HK; Romegialli A; Dadras SS
    Clin Dermatol; 2013; 31(3):317-23. PubMed ID: 23608451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ras, Raf, and MAP kinase in melanoma.
    Solus JF; Kraft S
    Adv Anat Pathol; 2013 Jul; 20(4):217-26. PubMed ID: 23752084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update in molecular diagnostics in melanocytic neoplasms.
    Cooper C; Sorrell J; Gerami P
    Adv Anat Pathol; 2012 Nov; 19(6):410-6. PubMed ID: 23060066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular testing for melanocytic tumors: a practical update.
    Andea AA
    Histopathology; 2022 Jan; 80(1):150-165. PubMed ID: 34958511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence in-situ hybridization analysis for melanoma diagnosis.
    Senetta R; Paglierani M; Massi D
    Histopathology; 2012 Apr; 60(5):706-14. PubMed ID: 22007736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melanoma pathology: important issues for clinicians involved in the multidisciplinary care of melanoma patients.
    Scolyer RA; Prieto VG
    Surg Oncol Clin N Am; 2011 Jan; 20(1):19-37. PubMed ID: 21111957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescence in situ hybridization as a diagnostic modality in melanocytic neoplasma.
    Gerami P; Geraminegad P
    G Ital Dermatol Venereol; 2010 Feb; 145(1):29-35. PubMed ID: 20197743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Main clues in the pathologic diagnosis of melanoma: is molecular genetics helping?
    Ferrara G; Senetta R; Paglierani M; Massi D
    Dermatol Ther; 2012; 25(5):423-31. PubMed ID: 23046021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular techniques for predicting behaviour in melanocytic neoplasms.
    Lee CY; Gerami P
    Pathology; 2016 Feb; 48(2):142-6. PubMed ID: 27020386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular testing in malignant melanoma].
    Dundr P; Staněk L; Němejcová K; Jakša R
    Cesk Patol; 2014 Jul; 50(3):127-31. PubMed ID: 25186593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathology of melanocytic lesions: new, controversial, and clinically important issues.
    Scolyer RA; Thompson JF; Stretch JR; Sharma R; McCarthy SW
    J Surg Oncol; 2004 Jul; 86(4):200-11. PubMed ID: 15221927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.